NCT00291096 High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
| NCT ID | NCT00291096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Carol Fabian, MD |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 1989-08 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 1989-08 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Eligibility Criteria
Inclusion Criteria: * women with at least 2 times the normal risk of developing breast cancer * between the ages of 30-65 (or within 10 years of youngest age at diagnosis in first degree relative) * greater than six months from ingestion of antihormonal therapy * greater than 1 year from pregnancy, lactation, or chemotherapy * willing to have a mammogram within six months prior to RPFNA * willing to discontinue NSAIDS or herbal supplements * willing to have blood drawn Exclusion Criteria: * no metastatic malignancy of any kind * no breast implants or tram flap reconstructions * no radiation to both breasts * no women who have a current mammogram or clinical breast exam suspicious for cancer
Contact & Investigator
Carol J Fabian, MD
PRINCIPAL INVESTIGATOR
University of Kansas Medical Center
Frequently Asked Questions
Who can join the NCT00291096 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 65 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00291096 currently recruiting?
Yes, NCT00291096 is actively recruiting participants. Contact the research team at bkimler@kumc.edu for enrollment information.
Where is the NCT00291096 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT00291096 clinical trial?
NCT00291096 is sponsored by Carol Fabian, MD. The principal investigator is Carol J Fabian, MD at University of Kansas Medical Center. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.